Rohit Vadgaonkar

Rohit Vadgaonkar


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Clinical Breast Cancer
Verified
Journal Article
Closed access
TWTabassum Wadasadawala
Tabassum Wadasadawala
RVRohit Vadgaonkar
Rohit Vadgaonkar
JBJyoti Bajpai
Jyoti Bajpai

12 May 2023 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
RVRohit Vadgaonkar
Rohit Vadgaonkar
PVPradeep Ventrapati
Pradeep Ventrapati
AMAnkita Mehta
Ankita Mehta
ADAnupurva Dutta
Anupurva Dutta
Radiation recall dermatitis (RRD) is an extremely rare phenomenon. A variety of factors such as antineoplastic agents, pharmaceutical agents, physical and environmental factors have been proposed to be the underlying cause of RRD. Only a handful cases have been reported till date, where trastuzumab is sought to be the triggering agent. The presentation of RRD varies from mild erythematous to extensive confluent dermatitis, resolving over a period of 1 to 2 weeks with conservative management. Most of the patients tend to tolerate rechallenge well without showing reappearance. We hereby describe a lady with breast cancer having RRD following administration of trastuzumab. She developed reaction 28 days post-radiotherapy and managed conservatively. Furthermore, she was rechallenged with the same dose, that she tolerated very well, without any reappearance. Hence, an acquaintance of the clinicians to this rare entity is essential for timely diagnosis and appropriate management.

21 September 2024 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
MNM. Nagesh
M. Nagesh
RVRohit Vadgaonkar
Rohit Vadgaonkar
KSK.K. Sreelakshmi
K.K. Sreelakshmi
RHRaghavendra Hajare
Raghavendra Hajare
PPPritam Parab
Pritam Parab
UMUmesh Mahantshetty
Umesh Mahantshetty
Radiotherapy (RT) relies on devices like thermoplastic masks (TMs), that are made up of specialized thermoplastic polymers, and used as an immobilization tool. The study aims to assess the practice of usage and reuse of TMs among radiation therapy technologists (RTTs) in India and explore their awareness of environmental impact during disposal. A cross-sectional survey was conducted among RTTs working in different healthcare settings. A structured questionnaire designed by a team of RTTs and radiation oncologists was used to collect responses. Questionnaire encompassed data pertaining to demographics, existing patient load, daily utilisation and reuse practice of TMs, preferred method of disposal and awareness of RTTs regarding environmental consequences associated with TM disposal. A total of 430 RTTs participated in the study, with a median age of 31 years and a median professional experience of 8 years. Among the participants, 213 (49.6 %) reported daily TM utilization in more than 50 patients. TM reuse was reported by 350 (81.1 %) RTTs, with 257 (60 %) reusing TMs in both curative and palliative treatments. Reuse of TMs was observed more commonly in RTTs working in government facilities (81.2 %). Regarding disposal preferences, 381 (88.6%) participants preferred discarding used TMs in biomedical waste and 64.8% of these ultimately ended up as discarded scrap. Awareness regarding adverse environmental impact associated with TM disposal was reported by 320 (74.4%) participant RTTs. The study highlights the prevalent practice of reuse of TMs, especially in curative treatments, government-run facilities and busy treatment settings. Additionally, it emphasises the imperative for enhanced bio-medical waste management practices to facilitate more effective handling and disposal of used TMs.

9 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
AMAnkita Mehta
Ankita Mehta
SKSridhar Kotta
Sridhar Kotta
SKSrawant Kotta
Srawant Kotta
SNSonali Susmita Nayak
Sonali Susmita Nayak
SVSwetha Velagala
Swetha Velagala
RVRohit Vadgaonkar
Rohit Vadgaonkar
Primitive embryonal tumours of the meninges are an exceedingly rare entity and has been predominantly reported in the paediatric population. It poses a unique challenge in establishing the diagnosis as it closely resembles meningioma. This makes the incorporation of sophisticated techniques such as immunohistochemistry, molecular studies, and genetic analysis mandatory to arrive at a confirmative diagnosis. We hereby report a case of a 13-year boy who was diagnosed with primitive embryonal tumour that was initially sought to be a meningioma. Alongside, we have also included a review of literature on this entity focussing on paediatric population, where only a handful of case reports have been published till date. Although these tumours are biologically aggressive, but they tend to have good response rate with treatment. Due to rarity of this entity, consensus on the management guidelines is lacking. However, an acquaintance to this entity is important amongst neuro-oncologists to decrease the possibility of misdiagnosis and improve the cure rates and survival.

28 January 2022 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Open access
DDDebojoyti Dhar
Debojoyti Dhar
RVRohit Vadgaonkar
Rohit Vadgaonkar
RMRaviteja Miriyala
Raviteja Miriyala
HKHimanshu Kalita
Himanshu Kalita
PPPritam Parab
Pritam Parab
UMUmesh Mahantshetty
Umesh Mahantshetty
Advancements in therapeutic interventions have led to significant improvement in the overall management of childhood cancer. Radiotherapy forms an important component of their treatment. Modern radiotherapy technique where an optimal therapeutic ratio can be obtained demands proper and adequate immobilization of the child. This can be technically challenging sometimes, particularly when the child is noncompliant. To address this hurdle, we have used this concept of “Superhero,” where we have decorated and painted the thermoplastic masks that often used in the head and neck and cranial irradiation. We have received adequate compliance for this method, and the need for anesthesia was slackened.

18 May 2022 in JCO Global Oncology
Verified
Journal Article
Open access
RVRohit Vadgaonkar
Rohit Vadgaonkar
DDDebojoyti Dhar
Debojoyti Dhar
VVVidya Viswanath
Vidya Viswanath
RMRaviteja Miriyala
Raviteja Miriyala
UMUmesh Mahantshetty
Umesh Mahantshetty
PURPOSE: Radiation therapy technologists (RTTs), being the frontline health care workers, are vulnerable to COVID-19 disease and subsequent detrimental consequences of the pandemic. Hence, the study was undertaken for the comprehensive assessment of adverse effects of COVID-19 pandemic on RTTs. MATERIALS AND METHODS: This cross-sectional, survey-based study was carried out among RTTs working in various cancer centers across India. Assessment was carried out by using a questionnaire comprising the demographic profile and a structured instrument to quantify psychological, social, financial, and professional impact of COVID-19 pandemic. Responses were collected between February 1, 2021, and April 31, 2021. RESULTS: Of 302 responders, more than two third of the RTTs were concerned for getting COVID-19 disease either outside the hospital (n = 210, 69.5%) or from patients or attendants (n = 220, 72.8%). More than one third of RTTs were very much concerned for increased financial burden of COVID-19 pandemic (n = 94, 34.1%), and one third (n = 92, 30.5%) were very much concerned for newly imposed restrictions. RTTs working in a private setup ( P = .000), living in a tier 1 city ( P = .028), and lacking the coverage of COVID-19 disease in health insurance ( P = .010) faced a significantly higher financial burden. RTTs living in tier 1 city ( P = .023) and those who were in profession for > 5 years ( P = .013) had significantly higher concern for ensuring proper sanitization of the professional environment. More than half (n = 171, 56.6%) were interested in taking COVID-19 vaccine. CONCLUSION: COVID-19 pandemic adversely affected psychosocial, financial, and professional well-being of RTTs even after subsidizing the initial wave, and a timely intervention is warranted for their well-being and to sustain oncologic facilities.